Tilray

-$1.13 (-7.22%) Today

+$0.05 (+0.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Tilray and other stocks, options, and ETFs commission-free!

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide.

CEO

Irwin David Simon

Employees

1,030

Headquarters

Nanaimo, British Columbia

Founded

2018

TLRY Key Statistics

Market Cap

6.98B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

32.66M

High Today

$15.67

Low Today

$14.48

Open Price

$15.37

Volume

19.93M

52 Week High

$67.00

52 Week Low

$4.41

TLRY News

BenzingaMay 7

Tilray Stock Is Getting Squeezed Between 2 Key Levels

Tilray Inc. (NASDAQ:TLRY) shares were trading higher Friday after a Jefferies analyst double upgraded the stock. The stock was double upgraded from Underperfor

BenzingaMay 7

Why Tilray's Stock Is Trading Higher Today

Tilray Inc (NASDAQ:TLRY) is trading higher Friday morning after Jefferies upgraded and raised its price target on the stock. What Happened: Jefferies analyst O

MarketWatchMay 7

Tilray shares soar 10% premarket after Jefferies upgrades to buy, says Aphria merger 'the perfect match'

Jefferies upgraded shares of the new Tilray Inc. TLRY, -11.01% to buy from underperform on Friday, and said the recent merger of the company with rival Aphria I

Analyst Ratings

7%

of 14 ratings

Buy

7.1%

Hold

85.7%

Sell

7.1%

TLRY Earnings

-$1.75

-$1.17

-$0.60

-$0.02

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.06 per share

Actual

-$1.75 per share